Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multidisciplinary consensus recommendations for the management of IDH-mutant grade 2 gliomas in Spain: a Delphi study.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Sept 2026

Esparragosa Vázquez Inés, Fortes de la Torre Inmaculada, Hilario Amaya, Iglesias Lozano Irene, Hernández-Laín Aurelio, Pineda Estela, Sepúlveda Sánchez Juan Manuel, Vaz-Salgado Maria Angeles

Abstract excerpt

PURPOSE: Management of IDH-mutant grade 2 gliomas is challenging due to tumor heterogeneity and uncertainties arising from new imaging modalities, diagnostic advances, and emerging targeted therapies. This study aimed to develop multidisciplinary consensus recommendations to standardize the diagnosis, treatment, and follow-up of these gliomas in Spain. METHODS: A multidisciplinary scientific committee drafted 85...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Consensus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to IDH1 gene

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Neoplasm Grading

Source

Open in PubMed Open full text

Identifiers

PMID: 41915118
DOI: 10.1007/s12094-026-04338-0
PMCID: PMC13499869

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multidisciplinary consensus recommendations for the management of IDH-mutant grade 2 gliomas in Spain: a Delphi study.PMID 41915118Read ↗

Low-grade IDH -mutant gliomas: from standard post-surgical treatments to novel IDH inhibitorsSemantic proximity Read ↗

Updates on the WHO diagnosis of IDH-mutant glioma.Semantic proximity Read ↗

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Semantic proximity Read ↗

Advances in the treatment of IDH-mutant gliomas.Semantic proximity Read ↗

IDH1 Mutation and World Health Organization 2016 Diagnostic Criteria for Adult Diffuse GliomasSemantic proximity Read ↗

The Role of Mutant IDH Inhibitors in the Treatment of Glioma.Semantic proximity Read ↗

Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.Semantic proximity Read ↗

Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomasSemantic proximity Read ↗

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.Semantic proximity Read ↗

Advanced imaging of IDH-mutant gliomas: Precision in diagnosis and management.Semantic proximity Read ↗

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee.Semantic proximity Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.